Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is a... Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 3.77 | 3.44638449584 | 109.39 | 116.23 | 109.34 | 1283268 | 114.05338437 | CS |
| 4 | -4.11 | -3.5047326682 | 117.27 | 119 | 105.175 | 1259493 | 112.30398627 | CS |
| 12 | -25.16 | -18.1897050318 | 138.32 | 154.61 | 105.175 | 1334120 | 124.42042153 | CS |
| 26 | -2.08 | -1.80492884415 | 115.24 | 154.61 | 105.175 | 1122283 | 124.50986592 | CS |
| 52 | -24.67 | -17.8988609156 | 137.83 | 157.9799 | 105.175 | 984648 | 129.41457858 | CS |
| 156 | 19.86 | 21.2861736334 | 93.3 | 157.9799 | 75.25 | 837403 | 116.96673795 | CS |
| 260 | 23.16 | 25.7333333333 | 90 | 157.9799 | 71.875 | 840115 | 109.77699261 | CS |
| Nessuna Discussione Trovata |
| Crea Discussione |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
